NasdaqGS:CGONBiotechs
CG Oncology (CGON) Valuation Check After Strong Recent Share Price Momentum
Why CG Oncology Is On Investors’ Radar
CG Oncology (CGON) has been drawing attention after a strong run in recent months, with the stock showing double digit gains over the past month and past 3 months.
See our latest analysis for CG Oncology.
With the share price at $62.80, CG Oncology has seen a 24.7% 1 month share price return and a 50.3% year to date share price return, while the 1 year total shareholder return stands at 138.8%, pointing to strong momentum over both shorter and longer...